|Articles|June 1, 2002
Pilot trial encourages further study of intracorneal lens
Trois Rivieres, Quebec-Early limited experience with an intracorneal hydrogel inlay (PermaVision, Anamed Inc., Lake Forest, CA) indicates this synthetic keratophakic implant offers a promising new method for the treatment of hyperopia, said Francis F. Roy, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Sight Sciences reports new data supporting long-term efficacy of OMNI Surgical System
2
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
3
When policy meets parenthood: Examining residency leave in ophthalmology
4
AAO 2025: 12-month outcomes of travoprost intracameral implant (iDose TR) in conjunction with cataract surgery
5















































.png)


